Author:
Kim Yu-Jin,Cubitt Beatrice,Chen Emily,Hull Mitchell V.,Chatterjee Arnab K.,Cai Yingyun,Kuhn Jens H.,de la Torre Juan C.
Funder
US National Institute of Allergy and Infectious Diseases (NIAID)
NIH/NIAID
JCT
Reference93 articles.
1. Host factors in positive-strand RNA virus genome replication;Ahlquist;J. Virol.,2003
2. From leflunomide to teriflunomide: drug development and immunosuppressive oral drugs in the treatment of multiple sclerosis;Aly;Curr. Neuropharmacol.,2017
3. Drug repositioning: identifying and developing new uses for existing drugs;Ashburn;Nat. Rev. Drug Discov.,2004
4. ML311: A Small Molecule that Potently and Selectively Disrupts the Protein-Protein Interaction of Mcl-1 and Bim: A Probe for Studying Lymphoid Tumorigenesis, Probe Reports from the NIH Molecular Libraries Program, Bethesda (MD);Bannister,2010
5. Teriflunomide (Aubagio(R)) for the treatment of multiple sclerosis;Bar-Or;Exp. Neurol.,2014
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献